Author

Ana Marcu

GenentechORCID 0000-0003-0808-8097Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Ana Marcu1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1

Frequent Co-Authors

Alexey I. NesvizhskiiiD· 1 shared Christopher RoseiD· 1 shared Fengchao YuiD· 1 shared Kristin L. LeskoskeiD· 1 shared Susan KlaegeriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexey I. NesvizhskiiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJun 2, 2026

Real-time artificial intelligence prediction of peptide characteristics and MSFragger search improves multiplexed quantification of non-canonical HLA presented peptides in clear cell renal cell carcinoma.

Ana Marcu, Kristin L. Leskoske, Fengchao Yu…·Christopher Rose

The paper introduces MIRA-MS, a real-time AI-guided acquisition method that improves quantification of non-canonical HLA peptides in clear cell renal cell carcinoma.

DOI 10.64898/2026.05.29.727942

humanproteomics

𝕏 PostBluesky